Trading
Dashboard
Events
Trading Holidays
MTF
Feedback & Queries
Investor Downloads
Policies & Procedures
Regional language
Demat Fund Transfer
Stocks for
Wealth Creation
Investor Charter Depository Participants
Investor Charter Stock Broker
Escalation Matrix
Investor Initiated KYC Validation
Client Pay In Bank Account
Dow Futures Chart
Daily Gong
@Daily Gong
Daily Gong
Daily Gong
Daily Gong
Freeze Unfreeze
Member Details
AP Details
Investor Grievence Filing
Account Opening Details
Member Details
Client Registration documents in Vernacular Languages
About
Overview
Board of Directors
Senior Management
Become a partner
Product
Investments
Our Business
Equity
Derivatives
Mutual Fund
IPO
Download
Software
Forms
Margin
MCX Margin
.Net
List of AP BSE/NSE
List of AP MCX
CC Sript
Manual LTP
Exposure
SIPSCH
BFC_CC_CO
Margin Calculator
Equity Shareholders
Report Equity Shareholders
Unsecured Creditors
Report Unsecured Creditors
Mutual Fund
MF mobile user Guide
MF web User Guide
Careers
Dashboard
Menu
Contact Us
Expert View
Risk Disclosure
18005720673
RO’s and AP
Direct Client
Manage My Profile
Account opening Flow chart
Complaint Redressal Process Flow
Login
Daily Gong Web Login
MF Login
BACK OFFICE APs Login
OLD BACK OFFICE CLIENTS LOGIN
NEW BACK OFFICE CLIENTS LOGIN
DG PARTNER LOGIN
×
Stocks for wealth creation
Client ID
Pan No:
Submit
CLOSE
X
Risk Disclosures on Derivatives
>
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>
On an average, loss makers registered net trading loss close to ₹ 50,000.
>
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
CLOSE
X
COMPANY
EQUITY
derivatives
mutual fund
IPO
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Market Info
Company Profile
Comparison
Comparison
VENUS REMEDIES LTD.
NSE :
VENUSREM
BSE :
526953
ISIN CODE :
INE411B01019
Industry :
Pharmaceuticals & Drugs
House :
Private
BSE
897.40
32.3 (+3.73 %)
PREV CLOSE (
)
865.10
OPEN PRICE (
)
860.00
BID PRICE (QTY)
0.00 (0)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
16603
TODAY'S LOW / HIGH (
)
844.00
908.35
52 WK LOW / HIGH (
)
285.8
950
NSE
896.60
35.55 (+4.13 %)
PREV CLOSE(
)
861.05
OPEN PRICE (
)
833.60
BID PRICE (QTY)
896.60 (68)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
94779
TODAY'S LOW / HIGH(
)
831.10
904.10
52 WK LOW / HIGH (
)
285.7
944.75
Peer Companies
Price (
)
Chg (
)
Chg (%)
EPS (
)
TTM P/E
Volume (000's)
1 Year Return (%)